» Articles » PMID: 33663550

HINT1 Neuropathy in Norway: Clinical, Genetic and Functional Profiling

Overview
Publisher Biomed Central
Specialty General Medicine
Date 2021 Mar 5
PMID 33663550
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autosomal recessive axonal neuropathy with neuromyotonia has been linked to loss of functional HINT1. The disease is particularly prevalent in Central and South-East Europe, Turkey and Russia due to the high carrier frequency of the c.110G > C (p.Arg37Pro) founder variant.

Results: In a cohort of 748 Norwegian patients with suspected peripheral neuropathy, we identified two seemingly unrelated individuals, compound heterozygous for a new variant (c.284G > A, p.Arg95Gln) and the most common pathogenic founder variant (c.110G > C, p.Arg37Pro) in the HINT1 gene. Probands presented with motor greater than sensory neuropathy of various onset, accompanied by muscle stiffness and cramps in the limbs. Furthermore, they displayed non-classical symptoms, including pain in the extremities and signs of central nervous system involvement. Haplotype analysis in both patients revealed a common chromosomal background for p.Arg95Gln; moreover, the variant was identified in Swedish carriers. Functional characterization in HINT1-knockout and patient-derived cellular models, and in HNT1-knockout yeast, suggested that the new variant is deleterious for the function of HINT1 and provided mechanistic insights allowing patient stratification for future treatment strategies.

Conclusion: Our findings broaden the genetic epidemiology of HINT1-neuropathy and have implications for molecular diagnostics of inherited peripheral neuropathies in Scandinavia.

Citing Articles

Delineating the genetic landscape of Charcot-Marie-tooth disease in Türkiye: Distinct distribution, rare phenotypes, and novel variants.

Cakar A, Candayan A, Bagirova G, Uyguner Z, Ceylaner S, Durmus H Eur J Neurol. 2025; 32(1):e16572.

PMID: 39776111 PMC: 11707620. DOI: 10.1111/ene.16572.


Small Complex Rearrangement in -Related Axonal Neuropathy.

Tessa A, Schifino M, Salvo E, Trovato R, Cesana L, Frosini S Genes (Basel). 2024; 15(11).

PMID: 39596683 PMC: 11593638. DOI: 10.3390/genes15111483.


Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.

Armirola-Ricaurte C, Zonnekein N, Koutsis G, Amor-Barris S, Pelayo-Negro A, Atkinson D Genet Med. 2024; 26(6):101117.

PMID: 38459834 PMC: 11180951. DOI: 10.1016/j.gim.2024.101117.


The most common European HINT1 neuropathy variant phenotype and its case studies.

Rozevska M, Rots D, Gailite L, Linde R, Mironovs S, Timcenko M Front Neurol. 2023; 14:1084335.

PMID: 36873433 PMC: 9981799. DOI: 10.3389/fneur.2023.1084335.


Case report: A novel homozygous histidine triad nucleotide-binding protein 1 mutation featuring distal hereditary motor-predominant neuropathy with rimmed vacuoles.

Jiang N, Vazquez Do Campo R, Kazamel M Front Neurol. 2023; 14:1007051.

PMID: 36846110 PMC: 9943687. DOI: 10.3389/fneur.2023.1007051.


References
1.
Gietz R, Schiestl R . High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat Protoc. 2007; 2(1):31-4. DOI: 10.1038/nprot.2007.13. View

2.
Rodriguez-Munoz M, Cortes-Montero E, Pozo-Rodrigalvarez A, Sanchez-Blazquez P, Garzon-Nino J . The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders. Oncotarget. 2015; 6(34):35458-77. PMC: 4742118. DOI: 10.18632/oncotarget.6064. View

3.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

4.
Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

5.
Flanagan S, Patch A, Ellard S . Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers. 2010; 14(4):533-7. DOI: 10.1089/gtmb.2010.0036. View